Cargando…
Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation
Vacuolar protein sorting 41 (VPS41) is as part of the Homotypic fusion and Protein Sorting (HOPS) complex required for lysosomal fusion events and, independent of HOPS, for regulated secretion. Here, we report three patients with compound heterozygous mutations in VPS41 (VPS41(S285P) and VPS41(R662)...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103106/ https://www.ncbi.nlm.nih.gov/pubmed/33851776 http://dx.doi.org/10.15252/emmm.202013258 |
_version_ | 1783689249899413504 |
---|---|
author | van der Welle, Reini E N Jobling, Rebekah Burns, Christian Sanza, Paolo van der Beek, Jan A Fasano, Alfonso Chen, Lan Zwartkruis, Fried J Zwakenberg, Susan Griffin, Edward F ten Brink, Corlinda Veenendaal, Tineke Liv, Nalan van Ravenswaaij‐Arts, Conny M A Lemmink, Henny H Pfundt, Rolph Blaser, Susan Sepulveda, Carolina Lozano, Andres M Yoon, Grace Santiago‐Sim, Teresa Asensio, Cedric S Caldwell, Guy A Caldwell, Kim A Chitayat, David Klumperman, Judith |
author_facet | van der Welle, Reini E N Jobling, Rebekah Burns, Christian Sanza, Paolo van der Beek, Jan A Fasano, Alfonso Chen, Lan Zwartkruis, Fried J Zwakenberg, Susan Griffin, Edward F ten Brink, Corlinda Veenendaal, Tineke Liv, Nalan van Ravenswaaij‐Arts, Conny M A Lemmink, Henny H Pfundt, Rolph Blaser, Susan Sepulveda, Carolina Lozano, Andres M Yoon, Grace Santiago‐Sim, Teresa Asensio, Cedric S Caldwell, Guy A Caldwell, Kim A Chitayat, David Klumperman, Judith |
author_sort | van der Welle, Reini E N |
collection | PubMed |
description | Vacuolar protein sorting 41 (VPS41) is as part of the Homotypic fusion and Protein Sorting (HOPS) complex required for lysosomal fusion events and, independent of HOPS, for regulated secretion. Here, we report three patients with compound heterozygous mutations in VPS41 (VPS41(S285P) and VPS41(R662) (*) ; VPS41 (c.1423‐2A>G) and VPS41(R662) (*)) displaying neurodegeneration with ataxia and dystonia. Cellular consequences were investigated in patient fibroblasts and VPS41‐depleted HeLa cells. All mutants prevented formation of a functional HOPS complex, causing delayed lysosomal delivery of endocytic and autophagic cargo. By contrast, VPS41(S285P) enabled regulated secretion. Strikingly, loss of VPS41 function caused a cytosolic redistribution of mTORC1, continuous nuclear localization of Transcription Factor E3 (TFE3), enhanced levels of LC3II, and a reduced autophagic response to nutrient starvation. Phosphorylation of mTORC1 substrates S6K1 and 4EBP1 was not affected. In a C. elegans model of Parkinson’s disease, co‐expression of VPS41(S285P)/VPS41(R662) (*) abolished the neuroprotective function of VPS41 against α‐synuclein aggregates. We conclude that the VPS41 variants specifically abrogate HOPS function, which interferes with the TFEB/TFE3 axis of mTORC1 signaling, and cause a neurodegenerative disease. |
format | Online Article Text |
id | pubmed-8103106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81031062021-05-10 Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation van der Welle, Reini E N Jobling, Rebekah Burns, Christian Sanza, Paolo van der Beek, Jan A Fasano, Alfonso Chen, Lan Zwartkruis, Fried J Zwakenberg, Susan Griffin, Edward F ten Brink, Corlinda Veenendaal, Tineke Liv, Nalan van Ravenswaaij‐Arts, Conny M A Lemmink, Henny H Pfundt, Rolph Blaser, Susan Sepulveda, Carolina Lozano, Andres M Yoon, Grace Santiago‐Sim, Teresa Asensio, Cedric S Caldwell, Guy A Caldwell, Kim A Chitayat, David Klumperman, Judith EMBO Mol Med Articles Vacuolar protein sorting 41 (VPS41) is as part of the Homotypic fusion and Protein Sorting (HOPS) complex required for lysosomal fusion events and, independent of HOPS, for regulated secretion. Here, we report three patients with compound heterozygous mutations in VPS41 (VPS41(S285P) and VPS41(R662) (*) ; VPS41 (c.1423‐2A>G) and VPS41(R662) (*)) displaying neurodegeneration with ataxia and dystonia. Cellular consequences were investigated in patient fibroblasts and VPS41‐depleted HeLa cells. All mutants prevented formation of a functional HOPS complex, causing delayed lysosomal delivery of endocytic and autophagic cargo. By contrast, VPS41(S285P) enabled regulated secretion. Strikingly, loss of VPS41 function caused a cytosolic redistribution of mTORC1, continuous nuclear localization of Transcription Factor E3 (TFE3), enhanced levels of LC3II, and a reduced autophagic response to nutrient starvation. Phosphorylation of mTORC1 substrates S6K1 and 4EBP1 was not affected. In a C. elegans model of Parkinson’s disease, co‐expression of VPS41(S285P)/VPS41(R662) (*) abolished the neuroprotective function of VPS41 against α‐synuclein aggregates. We conclude that the VPS41 variants specifically abrogate HOPS function, which interferes with the TFEB/TFE3 axis of mTORC1 signaling, and cause a neurodegenerative disease. John Wiley and Sons Inc. 2021-04-14 2021-05-07 /pmc/articles/PMC8103106/ /pubmed/33851776 http://dx.doi.org/10.15252/emmm.202013258 Text en © 2021 The Authors. Published under the terms of the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles van der Welle, Reini E N Jobling, Rebekah Burns, Christian Sanza, Paolo van der Beek, Jan A Fasano, Alfonso Chen, Lan Zwartkruis, Fried J Zwakenberg, Susan Griffin, Edward F ten Brink, Corlinda Veenendaal, Tineke Liv, Nalan van Ravenswaaij‐Arts, Conny M A Lemmink, Henny H Pfundt, Rolph Blaser, Susan Sepulveda, Carolina Lozano, Andres M Yoon, Grace Santiago‐Sim, Teresa Asensio, Cedric S Caldwell, Guy A Caldwell, Kim A Chitayat, David Klumperman, Judith Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation |
title | Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation |
title_full | Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation |
title_fullStr | Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation |
title_full_unstemmed | Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation |
title_short | Neurodegenerative VPS41 variants inhibit HOPS function and mTORC1‐dependent TFEB/TFE3 regulation |
title_sort | neurodegenerative vps41 variants inhibit hops function and mtorc1‐dependent tfeb/tfe3 regulation |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103106/ https://www.ncbi.nlm.nih.gov/pubmed/33851776 http://dx.doi.org/10.15252/emmm.202013258 |
work_keys_str_mv | AT vanderwellereinien neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT joblingrebekah neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT burnschristian neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT sanzapaolo neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT vanderbeekjana neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT fasanoalfonso neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT chenlan neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT zwartkruisfriedj neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT zwakenbergsusan neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT griffinedwardf neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT tenbrinkcorlinda neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT veenendaaltineke neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT livnalan neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT vanravenswaaijartsconnyma neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT lemminkhennyh neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT pfundtrolph neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT blasersusan neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT sepulvedacarolina neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT lozanoandresm neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT yoongrace neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT santiagosimteresa neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT asensiocedrics neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT caldwellguya neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT caldwellkima neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT chitayatdavid neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation AT klumpermanjudith neurodegenerativevps41variantsinhibithopsfunctionandmtorc1dependenttfebtfe3regulation |